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Abstract: Background and Objectives: Diabetes is a chronic and metabolic disease, considered as an
important public health problem. The objective of this study was to determine the prevalence of
podiatric pathology in type II diabetic patients. Materials and Methods: An observational descriptive
study of prevalence in the endocrinology service of Complexo Hospitalario Universitario A Coruña
(CHUAC) (A Coruña-Spain) was carried out (n = 153). Type II diabetic patients included, of legal
age who signed the informed consent. Sociodemographic variables were studied (age, sex, body
mass index (BMI), smoking habit, alcohol consumption, family history), disease variables (time of
evolution of diabetes, treatments, low-density lipoprotein (LDL), high-density lipoprotein (HDL),
glucose), podiatric variables: measurement of the footprint, metatarsal and digital formula, nail, skin,
hindfoot and forefoot alterations. The data collection was done in 2018 and the data analysis was
carried out in 2019. Results: The patients with type II diabetes had greater age, obesity and arterial
hypertension it compared to the general population. Diabetic patients had a higher prevalence of
flat feet than the general population (71.2% vs. 20.7%, p < 0.001), with a predominance of normal
foot according to the podoscope. The predominant podological pathology was the presence of claw
toes (94.8%), followed by dermal (78.4%) and nail (71.9%) alterations, and the Hallux Valgus (66.0%).
The Clarke angle and the Chippaux index showed a Kappa concordance index of 0.26 with the type of
footprint measured with the podoscope. The Staheli index showed a Kappa index of 0.27 associated
with an observed agreement of 54%. Conclusions: This study shows that foot problems continue to
be prevalent in subjects with type II diabetes mellitus and for this reason, podiatry is essential in
its treatment.
Keywords: foot; diabetes; podiatry
Highlighting
Updated information on podiatric pathology data in patients with type II diabetes mellitus. These
data can help to establish prevention criteria in clinical practice.
1. Introduction
Type II diabetes is increasing worldwide due to the current sedentary lifestyle, high obesity and
longer life expectancy [1].
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Diabetes is a chronic disease that presents a high morbimortality due to the complications that
develop during the evolution of the disease [2].
In Spain, the prevalence of diabetes mellitus (DM) is estimated at 9.4% (10.6% men, 8.2% women) [3].
The most important risk factors for DM are age, obesity and family history of DM. The prevalence of
the different chronic complications varies depending on the type of DM, the time of evolution of the
disease and the degree of metabolic control, with an estimate of 25% of neuropathy, 32% of retinopathy
and 23% of nephropathy [4].
Diabetes can cause serious complications at the level of the foot, among these complications
is diabetic neuropathy (loss of normal nervous function) that affects 40% of this population [5] and
peripheral vascular disease (loss of normal circulation) [6].
Diabetic neuropathy and vascular diseases are usually present in many diabetic patients.
Neuropathy is associated with metabolic abnormalities of diabetes and will cause insensibility
and deformities in the foot, which usually occur with a gait pattern with alterations. By joining the
diabetic neuropathy, peripheral vascular disease will cause any external pressure or friction of footwear
on the foot and can lead to an injury that may end in ulceration. The most frequent areas of ulceration
will be the fingers, the heel, and the bones of the ankle [6,7].
84% of ulcers that do not heal lead to amputations of the lower extremities of diabetic patients.
The frequency of mortality of diabetic patients after a major amputation varies from 11 to 41% in the
first year [6–8].
DM is one of the diseases with the greatest sociosanitary repercussions, not only because of the
frequency of this disease, but also because of the impact of the complications with which these patients
attend, as it happens with the feet. In this way, the complications in the feet affect to quality of life,
social participation and livelihood [1,8,9].
The fact of knowing the main foot problems can help to prevent and treat diabetic foot and avoid
serious complications such as amputations [7]. For all the above and the absence of relevant studies
on pathology at the level of the foot, the objective of this work was to determine the prevalence of
podiatric pathology in type II diabetic patients.
2. Materials and Methods
2.1. Design and Field of Study
An observational descriptive study of prevalence was carried out. It was carried out in the Service
of endocrinology and in the Clinical Epidemiology and Biostatistics Unit of the University Hospital
Complex of A Coruña (CHUAC) (A Coruña, Spain). This study is part of a broader multidisciplinary
study with endocrine, vascular, digestive, ophthalmologists and nursing staff (n = 505). From the
sample of patients included in the study (n = 505), a subsample was taken (n = 153) where the podiatry
scan was performed. The general and chiropody characteristics of these patients were compared with
a randomized population sample of the same geographical area (n = 1844). The foot examinations of
the patients included in the study were performed by podiatrists.
The data collection was done in 2018 and the data analysis was carried out in 2019.
2.2. Inclusion and Exclusion Criteria of the Sample Studied
Of the patients included, all of them type II diabetics, who were of legal age and who gave their
informed consent in writing. Type I diabetic patients with a history of cardiovascular and hepatic
disease were excluded, to ensure that the foot problems are focused on the diabetic disease and avoid
bias in the results. All the people included in the study went to the endocrinology clinic and the
characteristics of the study were explained to them. Those interested in participating were summoned
another day to sign the informed consent and to perform the explorations.
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2.3. Variables Studied and Procedure
The following variables were collected from each person included in the study: sociodemographic
variables (age, sex, Body Mass Index (BMI), smoking habit, alcohol consumption, and family history),
disease variables (time of evolution of diabetes, pharmacological treatments, low-density lipoprotein
(LDL), high-density lipoprotein (HDL), glucose), podiatric variables: measurements of the footprint
through podoscopy and pedigraphy. To study the footprint by pedigraph, three footprint measurements
were used: Clarke’s angle, Chippaux–Smirak and Staheli index [10]. These parameters are usually
used to categorize the footprint as cavus, flat or normal foot. The footprints were obtained by placing a
reticulated piece of rubber sheeting, tensed and impregnated with ink, between the subject’s foot and a
piece of stretched paper. In order to get an accurate footprint, it was performed while the participants
were sitting. They were also studied metatarsal and digital formula, nail changes, dermal, of the
hindfoot and forefoot, the absence of hair, skin color and temperature and the presence of edema were
also determined. The participants were on a stretcher to collect this data.
2.4. Ethical and Legal Aspects
The study is approved by the ethics committee of Galicia (CAEIG 2016/72; approval date: 25 May
2016). Furthermore, ethical and legal aspects were considered in this study. All participants were
informed of the objective of the study and its procedure. Informed consent was necessary to participate
in the study.
2.5. Statistical Analysis
A descriptive analysis of the variables included in the study was carried out, the quantitative
variables were expressed as mean ± standard deviation (SD) and the qualitative variables as frequency
(n) and percentage.
We compared the random sample with the general population, in turn, we compared the
podological characteristics of the sample studied according to sex. For the comparison of means,
the Student’s t-test or Mann–Whitney U test was used depending on the nature of the variables.
The association between qualitative variables was analyzed using the Chi-square test or Fisher’s test.
The concordance between the different image diagnoses and the diagnosis by means of a podoscope
were analyzed through the Kappa concordance index.
3. Results
3.1. Sociodemographic Characteristics of the Sample Studied
We analyzed 505 patients diagnosed with type II diabetes, whose general characteristics and
comorbidity (Table 1) were compared with the characteristics presented in the healthy general
population sample belonging to a previous study [11].
The sample of diabetic patients presented a mean age of 62.9 ± 7.9 years, higher than the age
presented by the general population. Diabetic patients had a higher prevalence of obesity (56.9%
vs. 39.2%) and HBP (42.4% vs. 36.5%) than the general population. Regarding smoking, there was
a greater predominance of smokers in the general population (17.5% vs. 2.6%), however, the same
distribution was determined according to sex in both samples.
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Table 1. General characteristics and comorbidity of diabetic patients, and comparison with those of





Mean (SD) Mean (SD) p
Age (years) 61.8(12.4) 62.9(7.9) 0.016
BMI (Kg/m2) 29.2(4.7) 31.7(5.4) <0.001
Abdominal perimeter (cm) 95.4(12.7) 105.6(13.8) <0.001
SAT 131.4(17.2) 82.2(10.1) <0.001
DAT 75.2(10.3) 141.1(17.7) <0.001
LDL 132.0(31.4) 101.3(30.2) <0.001
Glucose 99.2(26.6) 136.6(44.04) <0.001
Diabetes evolution time (years) 12.9(8.6)




















Insulin 35(1.9) 111(22.0) <0.001
Oral antidiabetics 174(9.6) 406(80.4) <0.001
Diet 297(63.6)
Exercise 287(61.2)
BMI: body mass index, SAT: systolic blood pressure, DAT: diastolic blood pressure, LDL: light density lipoproteins.
Numbers written in bold indicate statistically significant differences.
3.2. Podiatric Alterations
Podiatry exploration was carried out in a subsample of 153 diabetic patients (Table 2). Patients
with diabetes had a higher prevalence of flat foot than patients in the general population (71.2% vs.
20.7%, p < 0.001), among whom normal foot prevailed, according to the podoscope.
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n (%) n (%) p n (%) n (%) p
According to
podoscope: <0.001 0.260
Cavus 336(18.9) 21(13.7) 12(16.9) 9(11.0)
Normal 1075(60.4) 23(15.0) 13(18.3) 10(12.2)
Flat 369(20.7) 109(71.2) 46(64.8) 63(76.8)
Metatarsal formula 0.009 0.403
Index Plus 241(24.1) 20(13.1) 12(16.9) 8(9.8)
Index Plus-minus 349(35.0) 63(41.2) 27(38.0) 36(43.9)
Index Minus 407(40.9) 70(45.8) 32(45.1) 38(46.3)
Digital formula 0.058 0.403
Egyptian 565(57.1) 90(58.8) 45(63.4) 45(54.9)
Greek 311(31.4) 55(35.9) 22(31.0) 33(40.2)
Square 113(11.4) 8(5.2) 4(5.6) 4(4.9)
According to
image:
Clarke Angle <0.001 0.109
Cavus 434(27.5) 10(7.5) 7(11.7) 3(4.1)
Normal 892(56.5) 81(60.4) 38(63.3) 43(58.1)
Flat 254(16.1) 53(39.6) 15(25.0) 28(37.8)
Chippaux Index <0.001 0.084
Cavus 148(9.4) 12(9.0) 9(15.0) 3(4.1)
Normal 658(41.6) 83(61.9) 34(56.7) 49(66.2)
Flat 774(49.0) 39(29.1) 17(28.3) 22(29.7)
Staheli Index <0.001 0.297
Cavus 385(24.4) 41(30.6) 22(36.7) 19(25.7)
Normal 249(15.7) 41(30.6) 15(25.0) 26(35.1)
Flat 947(59.9) 52(38.8) 23(38.3) 29(39.2)
* Subsample of diabetic patients in which podiatric examination was performed. Numbers written in bold indicate
statistically significant differences.
More than 60% of the 153 diabetic patients presented normal foot according to the Clarke angle
and the Chippaux index (60.4% and 61.9% respectively), whereas the Staheli index determined a higher
prevalence of flat foot (38.8%) followed by a 30.6% normal foot. These classifications were similar in
terms of the sex of the patients.
3.2.1. Podiatric Alterations Depending on Sex
Table 3 shows the podiatric characteristics of the 153 patients diagnosed with diabetes according
to sex. It was found that 66% had Hallux Valgus, the prevalence being slightly higher in women (69.5%
vs. 62%, p = 0.326). 94.8% of the patients presented claw toes, presenting a similar prevalence in
both sexes. 71.9% presented nail disorders, the most prevalent being onychocryptosis (55.7%). 78.4%
presented dermal alterations (xerosis 25.5% and hyperkeratosis 64.1%), more frequent among women
(86.6% vs. 69%, p = 0.008). Forty-four percent of the patients presented abnormal coloration in the
skin of the lower extremities, being in this case more frequent in men (52.9% vs. 35.6%, p = 0.038).
In contrast, a higher prevalence of edema was observed in females (39.0% vs. 22.5%, p = 0.028).
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Table 3. Podiatry characteristics of diabetic patients.
Diabetic *
(n = 153)





n (%) n (%) n (%) p
Forefoot
alterations 0.634
No 149(97.4) 69(97.2) 80(97.6)
Yes 4(2.6) 2(2.8) 2(2.4)
Hallux Extensus 38(24.8) 20(28.2) 18(22.0) 0.375
Hallux Valgus 101(66.0) 44(62.0) 57(69.5) 0.326
Grades 0.662
Grade 1 47(46.5) 23(52.3) 24(42.1)
Grade 2 30(29.7) 12(27.3) 18(31.6)
Grade 3 13(12.9) 4(9.1) 9(15.8)
Grade 4 11(10.9) 5(11.4) 6(10.5)
Claw fingers 145(94.8) 68(95.8) 77(93.9) 0.725
2nd 132(86.3) 62(87.3) 70(85.4) 0.726
3rd 126(82.4) 61(85.9) 65(79.3) 0.282
4th 136(88.9) 66(93.0) 70(85.4) 0.136
Nail disorders 0.731
No 43(28.1) 19(26.8) 24(29.3)
Yes 110(71.9) 52(73.2) 58(70.7)
Onychocryptosis 78(55.7) 34(49.3) 44(62.0) 0.131
Onychogyphosis 18(12.9) 9(13.2) 9(12.5) 0.897
Onychodystrophy 18(13.0) 7(10.0) 11(16.2) 0.205
Onycholysis 4(2.9) 2(2.9) 2(2.9) 0.679
Dermal alterations 0.008
No 33(21.6) 22(31.0) 11(13.4)
Yes 120(78.4) 49(69.0) 71(86.6)
Xerosis 39(25.5) 17(23.9) 22(26.8) 0.683
Hyperkeratosis 98(64.1) 40(56.3) 58(70.7) 0.064
Absence of hair 0.494
No 86(56.2) 42(59.2) 44(53.7)
Yes 67(43.8) 29(40.8) 38(46.3)
Skin coloring 0.038
Normal 79(56.0) 32(47.1) 47(64.4)
Anormal 62(44.0) 36(52.9) 26(35.6)
Skin temperature 0.173
Normal 119(83.8) 54(79.4) 65(87.8)
Anormal 23(16.2) 14(20.6) 9(12.2)
Edema 0.028
No 105(68.6) 55(77.5) 50(61.0)
Yes 48(31.4) 16(22.5) 32(39.0)
* Subsample of diabetic patients in which podiatric examination was performed. Numbers written in bold indicate
statistically significant differences.
3.2.2. General Characteristics According to the Type of Footprint and the Podiatric Alterations
According to the type of footprint (Table 4), a higher BMI and abdominal perimeter was found
among patients with flat feet, as well as an increase in the presence of hyperkeratosis. The time of
evolution of the disease is slightly higher among patients with normal footprint, without 2nd toe claw
or without Hallux Valgus, without significant differences being observed. In turn, patients with 2nd
claw finger or Hallux Valgus had a higher prevalence of hyperkeratosis (64.4% and 67.3% respectively).
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Table 4. Characteristics of diabetic patients according to the type of footprint and the podiatric
alterations: 2nd claw toe and Hallux Valgus.
Type of Footprint
Mean (SD) Mean (SD) Mean (SD) p
Normal Cavus Flat
Age(years) 61.4(9.0) 64.7(6.6) 62.8±8.3 0.422
BMI (Kg/m2) 28.4(3.4) 26.7(3.1) 32.2(5.3) <0.001
n (%) n (%) n (%)
Sex 0.260
Men 13(56.5) 12(57.1) 46(42.2)
Woman 10(43.5) 9(42.9) 63(57.8)
Time of evolution (years) 11.7(6.9) 19.6(10.3) 12.6(8.5) 0.013
Abdominal perimeter (cm) 99.7(10.5) 97.5(10.1) 108.7(14.5) 0.001
Hyperkeratosis 0.006
No 14(60.9) 10(47.6) 31(28.4)
Yes 9(39.1) 11(52.4) 78(71.6)
2nd claw toe
No Yes p
Age(years) 61.8(10.7) 63.0(7.8) 0.985
BMI (Kg/m2) 30.7(5.79) 30.9(5.2) 0.674




Time of evolution (years) 16.2(7.2) 13.0(9.1) 0.054






Age (years) 62.1(9.8) 63.2(7.3) 0.603
BMI (Kg/m2) 31.3(5.5) 30.6(5.1) 0.461




Time of evolution (years) 14.6(8.3) 12.9(9.1) 0.109







BMI: body mass index. Numbers written in bold indicate statistically significant differences.
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3.2.3. Concordance Between Footprint According to the Podoscope
The concordance between the type of footprint according to the podoscope and the measurements
using the Clarke angle and the Chippaux and Staheli indexes was analyzed. A greater agreement
percentage was observed between the footprint type according to the podoscope and the Staheli index
(54%), followed by the Chippaux index (50%) and, to a lesser extent, the Clarke angle (49%). A Kappa
index between 0.26 (Chippaux index and Clarke angle) and 0.27 (Staheli index) was observed.
4. Discussion
This work constitutes a research that tries to cover the gaps of knowledge found in the literature
during the course of this work in Spain with a podiatric perspective, in which there has been a lack of
studies that tried to know the repercussion that type II diabetes mellitus triggers at the level of the foot.
Although we find in the literature different studies that tried to know the prevalence of diabetic
foot, and different alterations in the foot in people with this condition [12–14], we wanted to study
the impact in a broad way, knowing the repercussions at all levels of the foot: structural, dermal and
nail aspects.
Taking into account that among the risk factors for diabetes are age [15] and obesity [16,17],
our sample has a high age (62.9 ± 7.9 years) with a minimum age of around 40 years compared with
other studies found in the literature [18,19], likewise, we are struck by the high obesity present in our
study, a fact that is higher than the literature consulted [19].
In the present study we found a high presence of podiatric pathology, finding 94.8% of claw fingers,
data that are higher than that found in the general population as well as in the diabetic population
(9%) [17]. In relation to the deformity of Hallux valgus, we found in our study a prevalence of 66%;
we have not found any study with data on this pathology.
Alavi et al. and Vural et al. [19,20] studied nail changes as in our study, finding similar data on
onychodystrophy (13% in our study vs. 11% in the study by Vural et al. [19]). On the other hand,
we found a higher prevalence of onychogyphosis in our study (12.9% vs. 4% in the study by Vural
et al. 19). The results obtained in relation to onycholysis (2.9%) were lower than those found in the
literature [19,20].
Regarding the skin alterations, we found studies that dealt with xerosis and hyperkeratosis.
Regarding xerosis, we found a lower prevalence in this work compared to the literature reviewed [18,19].
On the other hand, the prevalence of hyperkeratosis was higher in this study, compared to the data
consulted [19,21–23].
In relation to the measurements in footprints, Plumarom et al. [24] discovered that the Staheli
index could be considered as the screening or diagnostic method for flatfoot. In our study, the major
of the footprints corresponded with flatfoot. Furthermore, we analyzed the concordance between
the methods with the podoscope, and we got the best agreement between the podoscope and the
Staheli Index.
Based on the findings of this study, it is possible to observe the importance that type II diabetes
mellitus triggers at the level of the lower limb, revealing the need for adequate podiatric prevention [25]
in patients with this pathology in collaboration with a multidisciplinary team.
Limitations
The results of the present study should be interpreted taking into account their possible limitations.
A potential problem with this study is that no data were collected from patients who refused to
participate, so the sample may not be representative of the population with diabetes. However, the
percentage of patients who declined to participate in the study was less than 5%, so it can be considered
that the representativeness of the sample has not been affected.
Regarding potential information biases, although they cannot be totally ruled out, several
strategies have been followed to avoid them. On the one hand, to minimize possible bias of the
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observer, the podiatric study has been carried out by two podiatrists who have agreed on the findings.
On the other hand, the measurement of subjective concepts that can be perceived differently by different
people, such as pain, functionality or health related to the foot, can be sources of bias. The use of
validated questionnaires such as those used in this study limits this problem, and also makes it possible
to compare the findings obtained with those of other similarly themed publications.
5. Conclusions
This study concluded with findings including a high prevalence of podiatric pathology in diabetic
patients, mainly flat feet, hallux valgus and claw toes. We found a predominance of skin alterations in
female patients, whereas abnormal color in the feet was more frequent in the male patients.
In order to substantiate the concordance between the type of footprint according to the podoscope
and the measurements studied in the footprint, the Staheli index showed a greater percentage according
to the type of footprint according to the podoscope than the Chippaux index and the Clarke angle,
showing a weak concordance in all three cases.
Author Contributions: Data collection: C.G.-M., R.V.-S.; conception and design of the study: C.G.-M., A.S.-G.,
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content: C.G.-M., S.P.-D., T.S.-P., V.B.-B., A.S.-G., R.V.-S.
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